Use of Frequency Distribution Curves, Scattergrams and Regression Analyses to CompareIn VitroActivities and Describe Cross-Susceptibility and Cross-Resistance Among Four Quinolones
- 1 December 1994
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 6 (6) , 368-376
- https://doi.org/10.1080/1120009x.1994.11736491
Abstract
Minimum inhibitory concentrations (MICs) of ciprofloxacin, ofloxacin, lomefloxacin, and fleroxacin for 852 recent clinical isolates were determined by a standardized broth microdilution method. Frequency distribution curves, scattergrams and regression analyses were used to compare in vitro activities and describe cross-susceptibility and cross-resistance. All four quinolones were active against most species tested except Xanthamonas maltophilia, enterococci, methicillin-resistant staphylococci and Bacteroides species. Relative in vitro activities were ciprofloxacin > ofloxacin > lomefloxacin = fleroxacin. Some of the in vitro advantages of ciprofloxacin, particularly when compared to ofloxacin, were negated when percents susceptible, based on pharmacokinetically derived breakpoints, were considered. Despite differences in in vitro activities, organisms relatively susceptible to one quinolone were relatively susceptible to all quinolones and organisms relatively resistant to one were relatively resistant to all; using regression analysis, coefficients of determination (R2) were 0.91-0.96 for all drug pairs. There was, therefore, a high degree of cross-susceptibility and cross-resistance. Differential categorizations of susceptibility to the quinolones would be justified only if validated by comparative clinical trials.Keywords
This publication has 9 references indexed in Scilit:
- In vitro activity of Bay y 3118, a new quinoloneAntimicrobial Agents and Chemotherapy, 1993
- Cross-resistance and cross-susceptibility between fluoroquinolone agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance risesAntimicrobial Agents and Chemotherapy, 1991
- The in-vitro activity of tosnfloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacinJournal of Antimicrobial Chemotherapy, 1991
- In-vitro activity of sparfloxacin, a new quinolone antimicrobial agentJournal of Antimicrobial Chemotherapy, 1990
- Mechanisms of resistance to the 4-quinolone antibacterial agentsJournal of Antimicrobial Chemotherapy, 1990
- In vitro Properties of the QuinolonesPublished by Elsevier ,1988
- The comparative in-vitro activity of pefloxacinJournal of Antimicrobial Chemotherapy, 1986
- In vitro activity of ciprofloxacin (Bay o 9867)Antimicrobial Agents and Chemotherapy, 1983